Find Clinical Trials & Studies

Visit the Research & Education Institute

CAR-T Based Immunotherapy for B-Cell Non-Hodgkin Lymphoma

I'm Interested!

Please call
1-800-641-2422

A Phase 1/1b Multicenter, Open Label Study to Evaluate the Safety of UF-KURE19 Cells in Patients With B Cell Non-Hodgkin Lymphomas

Sex: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: Cancer - Non-Hodgkin Lymphoma

Study Purpose

This study seeks to determine the safety and efficacy of the infusion of autologous CD19 CAR-T cells that are manufactured using an ultra-fast process.

Who Can Participate

Participants 18 years and older who have been diagnosed with relapsed or refractory non-Hodgkin lymphoma treated may be eligible for this study.

Principal Investigator
Changchun Deng MD

Department/Division
Cancer (Lymphoma)

UH IRB: STUDY20220867, 23-315
StudyID: CASE2422
ClinicalTrials.gov: NCT05400109

I'm Interested!

Please call
1-800-641-2422

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422